What does the evidence say about Lactobacillus Helveticus Stress Randomized Trial?

Updated October 2026

Quick Answer

Lactobacillus Helveticus Stress Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs.

Key Takeaways

  • 01Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. [Drzymała S (2026)]
  • 02Background : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression. [Drzymała S (2026)]
  • 03The aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19. [Drzymała S (2026)]
The current Migaku evidence database contains 1 reusable source document for Lactobacillus Helveticus Stress Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. [Drzymała S (2026); evidence level 2] - Background : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression. [Drzymała S (2026); evidence level 2] - The aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19. [Drzymała S (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.